Dietary (Phyto)Nutrients for Glutathione Support: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Peter Tang and Version 1 by Deanna M Minich.

Glutathione is a tripeptide that plays a pivotal role in critical physiological processes resulting in effects relevant to diverse disease pathophysiology such as maintenance of redox balance, reduction of oxidative stress, enhancement of metabolic detoxification, and regulation of immune system function. The diverse roles of glutathione in physiology are relevant to a considerable body of evidence suggesting that glutathione status may be an important biomarker and treatment target in various chronic, age-related diseases. 

  • broccoli
  • cancer prevention
  • cruciferous vegetables
  • glutathione
  • glutathione S-transferase
  • green tea
  • nutrigenomics
  • phytonutrients
  • plant-based diet
  • selenium
  • vitamins

1. Introduction

Glutathione is a tripeptide (cysteine, glycine, and glutamic acid) found in relatively high concentrations in many bodily tissues [1]. It plays a pivotal role in reducing oxidative stress, maintaining redox balance, enhancing metabolic detoxification, and regulating the immune system [1]. Various chronic, age-related diseases such as those related to neurodegeneration, mitochondrial dysfunction, and even cancer, have been related to suboptimal or deficient glutathione levels [1,2,3][1][2][3]. There is increasing awareness of its utility in mitigating body toxin load through its ability to enhance hepatic conversion and excretion of compounds such as mercury and persistent organic pollutants (POPs) [1,4,5][1][4][5].
As a result, it is possible that supporting the body’s endogenous levels of glutathione would be important for maintaining health and mitigating disease, although clear causal relationships between low glutathione and disease risk remain to be determined. One confounding factor is the complexity of antioxidants, referred to by Halliwell [6] as the “antioxidant paradox”, or the situation in which antioxidants such as glutathione can possess prooxidant activity causing a hormetic effect enabling the body to bolster its endogenous antioxidant defenses. Indeed, redox balance can be the cause or consequence of a disease, and in some cases, it is difficult to know the level at which an antioxidant becomes a prooxidant. Therefore, there is much to understand about the role of glutathione levels in health.
A factor influencing glutathione status is the degree of variability in an individual’s capacity to produce glutathione, mainly due to genetic variability in enzymes involved in its production and/or regeneration. The enzymes that have received increased attention in the scientific literature and within clinical medicine include glutathione-S-transferase and gamma-glutamyl transferase. Some of these enzymes require nutrient cofactors [1] (Figure 1). With upregulated oxidative stress, malnutrition or increased toxic burden due to exposure to environmental contaminants, there can be even greater need for glutathione [7,8,9][7][8][9]. A list of some proposed disease states related to inadequate glutathione status are listed in Table 1.
Figure 1. Hepatic synthesis of glutathione and nutritional substrates, co-factors, and other nutrients that influence metabolism. Key: 5-Methyl-tetrahydrofolate (5MTHF), system alanine–serine–cysteine (ASC), cystathionine-β-synthase (CBS), cystathionine gamma-lyase (CGL), electrophile response element (EpRE), glutathione-S-transferase (GST), glutamate cysteine ligase (GCL), glutathione reductase (GRx), glutathione peroxidase (GPx), glutathione synthetase (GSx), hydrogen peroxide (H2O2), Nuclear factor erythroid factor-2-related factor 2 (Nrf2), S-adenosylmethionine (SAMe), S-adenosylhomocysteine (SAH), tetrahydrofolate (THF), thioredoxin reductase 1 (TRR1), water (H2O), cystine/glutamate antiporter system (xc−). Description: Folic acid is reduced to THF and converted to 5MTHF which can subsequently be transferred to homocysteine and generate methionine. Methionine forms SAMe, which produces SAH from methylation reactions. SAH is hydrolyzed to homocysteine. Homocysteine can either regenerate methionine or be directed to the trans-sulfuration pathway forming cystathionine via the catalytic activity of CBS and serine. CGL cleaves the sulfur–gamma carbon bond of cystathionine, resulting in the release of cysteine which can be used by GCL and GSx to form glutathione. Extracellular cysteine can be either taken up by the cysteine transporter ASC or oxidized to cystine and taken up by system xc−. N-acetylcysteine can donate cysteine or reduce plasma cystine to cysteine. Intracellular cystine is reduced to cysteine via TRR1 or glutathione. The synthesis of γ-glutamyl cysteine is catalyzed by GCL from cysteine and glutamate, and the addition of glycine to γ-glutamyl cysteine via GSx generates glutathione. GPx catalyzes the reduction of H2O2 by glutathione and forms reduced glutathione which is then recycled to glutathione by GRx. Glutathione can also form adducts and conjugate xenobiotics via GST. Oxidative stress activates the Nrf2 pathway which induces EpRE-dependent gene expression of enzymes involved in glutathione metabolism, including GCL, GSx, GPx, and GST, to re-establish cellular redox homeostasis. Modified and developed from [10,11,12,13,14][10][11][12][13][14].
Table 1.
Clinical conditions and diseases associated with glutathione.

Research has found that many chronic diseases are associated with a reduction in glutathione levels, leading to the hypothesis that increasing glutathione levels can help prevent and/or mitigate the progression of these diseases. Below is a list of some of the diseases [2] and issues associated with glutathione dysregulation or deficiency [3]:

• aging [15] and related disorders [3]

• Alzheimer’s disease [16]

• cancer [17]

• chronic liver disease [18]

• cognitive impairment [19]

• cystic fibrosis [20]

• diabetes [21], especially uncontrolled diabetes [22]

• human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) [23]

• hypertension [24]

• infertility in both men and women [25]

• lupus [26]

• mental health disorders [27]

• multiple sclerosis [28]

• neurodegenerative disorders [29]

• Parkinson’s disease [30]
While there may be a need to repair low levels of glutathione, proper balance, rather than excess, is required. For example, glutathione may need monitoring in patients undergoing chemotherapy due to the potential to support chemoresistance [17]. There are challenges in the use of glutathione as a diagnostic biomarker and therapeutic target. Red blood cell (RBC) glutathione is readily available as a clinical assessment but has been found to have wide intra-individual variation [31]. However, this intra-individual variation is relatively stable over time which is a phenomenon likely due to variation in genes regulating glutathione levels in RBCs [32].

2. The Role of Gene Deletions and Single Nucleotide Polymorphisms (SNPs)

There are some common single nucleotide polymorphisms (SNPs) that impact glutathione and associated processes and may subsequently influence disease risk. These code for the enzyme glutathione S-transferase (GST), which conjugate the reduced glutathione to substrates during the detoxification process [34][33]. GSTP1 and GSTM1 do have multiple SNPs (for example, GSTP1 rs1695, A105G results in an amino acid substitution in codon 105 from valine to isoleucine associated with increased cancer risk), however, the null alleles described and focused on in this review ere result from gene deletion between the H3 and H5 regions flanking the gene [35][34]. During times of oxidative stress, GST genes are upregulated. One of the most common polymorphisms, affecting 20% to 50% of certain populations, is an absence of the GSTM1 gene (GSTM1-null), which decreases detoxification ability among other possible outcomes [36][35]. GSTT1 (null) and GSTP1 (AB/BB) are additional polymorphisms related to a reduction in GST activity [37][36]. Having one or more of these polymorphisms is associated with an increased risk of certain diseases [37][36], especially when impacted by environmental triggers such as pollution, smoking, heavy metals, and other toxins.

3. Optimizing Glutathione Production with Nutrients

Whether due to the presence of SNPs, gene deletions or heightened physiological need due to exogenous reasons like toxic load, to some extent, glutathione levels may be supported by dietary and/or supplemental nutrients. This review article will attempt to review the salient human clinical literature to support the use of specific foods and nutrients that may increase or maintain optimal glutathione levels.

4. Preformed Glutathione

It would seem to be most efficient to administer oral glutathione as a preformed compound to override the effects of potentially inefficient SNPs and related enzymes. However, there has been some debate regarding whether glutathione given orally would be degraded by digestive peptidases [37,38][36][37]. In further support of this theory, some studies [39,40,41][38][39][40] have shown no change in glutathione levels or in parameters of oxidative stress despite acute [40,41][39][40] or chronic (four weeks) [39][38] oral glutathione supplementation.
There is also some evidence to the contrary. One six-month, randomized, double-blinded, placebo-controlled trial [42][41] found that taking oral glutathione at either 250 or 1000 mg/day led to significant increases in the body stores of glutathione in 54 non-smoking adults in a dose-dependent manner. There was also a decrease in the markers for oxidative stress at six months as indicated through an improvement in the oxidized (GSSG) to reduced (GSH) glutathione ratio in whole blood, in conjunction with favorable increases in natural killer cell cytotoxicity.

5. N-Acetylcysteine (NAC)

Three conditionally essential amino acids, glycine, cysteine, and glutamic acid combine to form glutathione in a two-step biochemical reaction. First, cysteine is conjoined with glutamate through the action of glutamate cysteine ligase to produce gamma-glutamylcysteine, which proceeds to link with glycine via glutathione synthase [48][42]. Therefore, the human body requires all three amino acids and adequate enzymatic function to make sufficient quantities of glutathione [49,50][43][44]. Cysteine is a sulfur amino acid, which might imply that consuming sulfur-rich foods, especially those containing the sulfur amino acids, may also support glutathione synthesis [51,52][45][46].
Cysteine is frequently identified as rate-limiting, which provides the rationale of why N-acetylcysteine (NAC) is frequently studied and suggested as a supplement for glutathione support [50][44], yet a review of the data indicates its use may be inconclusive or equivocal. A systematic review [53][47] that included twelve clinical trials utilizing NAC supplementation with a specific focus on cognitive markers indicated that there may be some benefit to using NAC in certain populations; however, the studies were too variable in design and outcome to make any definitive conclusion. As a suggestion in future studies, including a genotype segmentation for participants for glutathione-related enzymes such as GST may lead to different findings and assist in investigating who is more primed for an effect.

6. Dietary Protein Considerations

Theoretically, impaired protein digestion may also be a limiting factor in ensuring healthy glutathione levels. A lack of or reduced hydrochloric acid production in the gastric mucosa and/or pancreatic enzyme insufficiency would be important to assess in a patient with low plasma albumin and low glutathione levels and/or symptoms of impaired glutathione activity (e.g., fatigue). Hypochlorhydria may, in fact, be more common in the aging population as the gut physiology changes [64][48], and the use of certain medications can also impact hydrochloric acid levels [65][49]. Further, oxidative stress (such as seen with low physiological glutathione levels) [66,67][50][51] and certain nutrient deficiencies [68][52] may also contribute to low stomach acid levels.
Since the precursors and foundation of glutathione are amino acids, intake of dietary protein may influence the amino acid pool from which to draw to synthesize glutathione. Changes in protein consumption [69][53], including reducing protein levels but remaining within safe levels, may alter plasma glutathione synthesis levels contributing to a reduction in antioxidant capacity. In this studyHere, the researchers found that while individuals were able to recover from a reduction in protein (that remained above the lowest amount considered safe) in terms of nitrogen balance, it took longer for the functional changes in glutathione levels to equilibrate. Urinary excretion of 5-L-oxoproline was suggested as a marker to track glutathione kinetics, particularly the availability of glycine.

7. Omega-3 Fatty Acids

Chronic inflammation can contribute to oxidative stress and deplete glutathione supply [75][54]. Due to their involvement in the production of inflammatory and anti-inflammatory prostaglandins, omega-3 fatty acids have been studied for their effects on glutathione levels. In one study [76][55] taking 4000 mg of omega-3 supplements daily for 12 weeks led to a better GSH–creatine ratio and reduced depressive symptoms in older adults who had a higher risk of developing depression compared with the control group taking a placebo. Another study in patients with Parkinson’s disease found that taking 1000 mg omega-3 fatty acids from flaxseed oil in conjunction with 400 IU of vitamin E for 12 weeks led to an increase in glutathione concentrations as well as total antioxidant capacity and a reduction in the inflammatory marker, high-sensitivity C-reactive protein, and markers of insulin metabolism [77][56].

8. Vitamins

8.1. B Vitamins

Riboflavin is a necessary coenzyme for the activity of glutathione reductase, which converts the oxidized glutathione into its reduced form, the compound required for antioxidant function [82][57]. While there is a paucity of studies to confirm that riboflavin deficiency negatively impacts glutathione levels, there is indication that homocysteine production and methylation processes require riboflavin [83,84][58][59]. Since the methylation cycle is closely linked to that of the trans-sulfuration pathways and glutathione metabolism, riboflavin levels could be important. Thus, it is likely that a riboflavin deficiency would impact glutathione function and may even impact the levels in the body. From a biochemical perspective, pantothenic acid (vitamin B5) may also help support glutathione synthesis through its role in ATP production [85][60]. B12 deficiency [86][61] is associated with lower glutathione levels.

8.2. Vitamin C

In 48 individuals with ascorbate deficiency [87][62], taking 500 or 1000 mg per day of vitamin C for 13 weeks led to an 18% increase in lymphocyte glutathione levels compared with placebo. Similarly, in healthy adults following a self-selected vitamin C-restricted diet [88][63] and an initial week of placebo supplementation, taking 500 mg L-ascorbate per day for weeks two and three and 2000 mg per day for weeks four and five in a six-week trial led to an increased level of glutathione in red blood cells. The lower dose of 500 mg daily led to the most pronounced rise in glutathione levels.

8.3. Vitamin E

Vitamin E supplementation has been studied to a limited extent in diabetic populations subject to higher endogenous oxidative stress levels [89,90][64][65]. In type 1 diabetic children [91][66], vitamin E supplementation (DL-alpha-tocopherol, 100 IU oral daily dose) significantly increased glutathione by 9% and lowered lipid peroxidation (malondialdehyde) by 23% and HbA1c concentrations by 16% in erythrocytes. A similar study [92][67] in 20 children with type 1 diabetes and 20 healthy controls found that 600 mg/day of vitamin E for three months improved oxidative stress markers and glutathione levels in the diabetic children. In adults (n = 54) with diabetic neuropathy [93][68], the group provided with a vitamin E supplement (800 IU/day) for 12 weeks had significant improvements in cardiometabolic parameters and plasma glutathione levels compared to the group given the placebo.

9. Other Nutrients

9.1. Alpha-Lipoic Acid

Alpha-lipoic acid is a multifunctional compound in its ability to serve as a direct scavenger of free radical species and to also help in the regeneration of endogenous antioxidants such as glutathione. A variety of clinical trials in diverse populations [94,95,96,97,98,99][69][70][71][72][73][74] would suggest that alpha-lipoic acid could be important for restoring antioxidant capacity. Children with oxidative stress due to protein malnutrition where given either 600 mg reduced glutathione twice daily, 50 mg alpha-lipoic acid twice daily, or 100 mg NAC twice daily for 20 days [100][75]. Glutathione and alpha-lipoic acid improved survival rates in these children, compared with the control group. HIV-infected adults (n = 33) assigned to either 300 mg alpha-lipoic acid three times daily or placebo for six months resulted in elevated blood total glutathione and lymphocyte response in the therapeutic group relative to the control group [101][76].

9.2. Selenium

Selenium is a known antioxidant and cofactor of glutathione peroxidase. In a mouse study [102][77], selenium supplementation increased the expression and activity of certain glutathione-related enzymes. Another study [103][78] in 336 healthy adults, (161 blacks, 175 whites) found a positive relationship between selenium levels and selenium supplementation. Despite similar selenium supplementation levels, glutathione levels increased to a greater extent in whites than blacks. It is worthwhile to note that excess selenium may contribute to oxidative stress rather than relieve it and this effect may be related to certain genotypes [104][79].

9.3. Phytonutrients

There can be potentially mixed clinical results from supplementation with supraphysiological doses of antioxidant vitamins and minerals in isolation, separate from their phytonutrient counterparts. One disadvantage may involve disturbing the redox state of a cell towards a predominantly prooxidant status [105][80]. Therefore, it might seem that one of the safer approaches to fortifying the innate defense against oxidative stress and improving glutathione levels may be best implemented through the diversity and pleiotropism of multiple phytonutrients. In support of this theory, fruit and vegetable intake has been shown to reduce oxidative stress [106][81], even in intervention studies [107,108,109,110,111][82][83][84][85][86]. There needs to be sustainable, creative ways for people to get their daily intake of fruits and vegetables as this quota is not being met by the vast majority [112][87].

9.4. Brassica Vegetables

There is a plethora of research to suggest the detoxification and cancer preventative qualities of cruciferous vegetable intake [122[88][89],123], especially for cancers related to the gastrointestinal tract [124][90]. Studies [125,126][91][92] have shown that administration of cruciferous-derived compounds, such as sulforaphane, may increase glutathione, glutathione-related enzymes, and even endogenous antioxidant enzymes and inflammatory markers, although results are not always consistent [115][93]. These compounds may be especially important for individuals with GST polymorphisms.

9.5. Green Tea

Green tea consumption is associated with reduced rates of certain cancers such as leukemia [134][94]. In a multicenter case–control study [134][94] in China with 442 confirmed adult leukemia cases and 442 controls, green tea intake and GST genotypes were assessed. Researchers found not only an inverse association between drinking green tea and adult leukemia risk compared with those who did not drink tea, but that cancer risk reduction was more pronounced in those with the GSTT1-null genotype than the GSTT1-present carriers.

9.6. Juice Studies

For those for whom eating fruits and vegetables is challenging, drinking juice derived from these foods may provide another healthful option, although some health professionals might be concerned with their simple sugar content. Generally, clinical studies would suggest that drinking fruit and/or vegetable juices confer health benefits, such as improving antioxidant status [136,137,138,139][95][96][97][98].

9.7. Herbs and Roots

While there is a lack in human clinical trial data, there are several animal studies which would indicate that certain herbs and roots, such as rosemary [144[99][100][101],145,146], turmeric/curcumin [147][102], milk thistle [148][103], and Gingko biloba [149][104], may influence glutathione levels. Rosemary extract in the diet of female rats at concentrations of 0.25% to 1.0% by weight resulted in a 3.5- to 4.5-fold increase in hepatic GST. An increase was seen when injected intraperitoneally but to a lesser extent [145][100]. In an animal study, a turmeric extract and curcumin were shown to increase hepatic glutathione content [150][105].

9.8. Plant Foods that Contain Glutathione

While the focus of this revisewarch has been on foods and dietary-derived nutrients for the purpose of supporting antioxidant defenses, primarily by increasing glutathione levels and enzymes related to glutathione’s activity, it is worthwhile to note that there are several foods that contain the thiol-rich compounds, glutathione, NAC, and cysteine. Eating a glutathione-supported diet could involve the inclusion of these foods daily, especially the green foods, asparagus, avocado, cucumber, green beans, and spinach.

References

  1. Pizzorno, J. Glutathione! Integr. Med. 2014, 13, 8–12.
  2. Franco, R.; Schoneveld, O.J.; Pappa, A.; Panayiotidis, M.I. The central role of glutathione in the pathophysiology of human diseases. Arch. Physiol. Biochem. 2007, 113, 234–258.
  3. Ballatori, N.; Krance, S.M.; Notenboom, S.; Shi, S.; Tieu, K.; Hammond, C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009, 390, 191–214.
  4. Pompella, A.; Emdin, M.; Franzini, M.; Paolicchi, A. Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? Clin. Chem. Lab. Med. 2009, 47, 1583–1584.
  5. Lee, D.H.; Jacobs, D.R., Jr. Hormesis and public health: can glutathione depletion and mitochondrial dysfunction due to very low-dose chronic exposure to persistent organic pollutants be mitigated? J. Epidemiol. Commun. Health 2015, 69, 294–300.
  6. Halliwell, B. The antioxidant paradox: less paradoxical now? Br. J. Clin. Pharmacol. 2013, 75, 637–644.
  7. Feoli, A.M.; Siqueira, I.; Almeida, L.M.; Tramontina, A.C.; Battu, C.; Wofchuk, S.T.; Gottfried, C.; Perry, M.L.; Gonçalves, C.A. Brain glutathione content and glutamate uptake are reduced in rats exposed to pre- and postnatal protein malnutrition. J. Nutr. 2006, 136, 2357–2361.
  8. López-López, A.L.; Jaime, H.B.; Escobar Villanueva, M.D.C.; Padilla, M.B.; Palacios, G.V.; Aguilar, F.J.A. Chronic unpredictable mild stress generates oxidative stress and systemic inflammation in rats. Physiol. Behav. 2016, 161, 15–23.
  9. Lee, D.H.; Jacobs, D.R., Jr. Serum gamma-glutamyltransferase: new insights about an old enzyme. J Epidemiol. Commun. Health 2009, 63, 884–886.
  10. Hall, M.N.; Niedzwiecki, M.; Liu, X.; Harper, K.N.; Alam, S.; Slavkovich, V.; Gamble, M.V. Chronic arsenic exposure and blood glutathione and glutathione disulfide concentrations in Bangladeshi adults. Environ. Health Perspect. 2013, 121, 1068–1074.
  11. Nebraska Redox Biology Center Educational Portal. Available online: http://genomics.unl.edu/RBC_EDU/gp.html (accessed on 7 July 2019).
  12. Allocati, N.; Masulli, M.; Di Ilio, C.; & Federici, L. Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis 2018, 7, 8.
  13. Lu, S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 1999, 13, 1169–1183.
  14. Wu, G.; Fang, Y.Z.; Yang, S.; Lupton, J.R.; Turner, N.D. Glutathione metabolism and its implications for health. J. Nutr. 2004, 134, 489–492.
  15. Lang, C.A.; Mills, B.J.; Lang, H.L.; Liu, M.C.; Usui, W.M.; Richie, J., Jr.; Mastropaolo, W.; Murrell, S.A. High blood glutathione levels accompany excellent physical and mental health in women ages 60 to 103 years. J Lab. Clin. Med. 2002, 140, 413–417.
  16. Saharan, S.; Mandal, P.K. The emerging role of glutathione in Alzheimer’s disease. J. Alzheimers Dis. 2014, 40, 519–529.
  17. Traverso, N.; Ricciarelli, R.; Nitti, M.; Marengo, B.; Furfaro, A.L.; Pronzato, M.A.; Marinari, U.M.; Domenicotti, C. Role of glutathione in cancer progression and chemoresistance. Oxid. Med. Cell Longev. 2013, 2013, 972913.
  18. Czuczejko, J.; Zachara, B.A.; Staubach-Topczewska, E.; Halota, W.; Kedziora, J. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochim. Pol. 2003, 50, 1147–1154.
  19. Rae, C.D.; Williams, S.R. Glutathione in the human brain: Review of its roles and measurement by magnetic resonance spectroscopy. Anal. Biochem. 2017, 529, 127–143.
  20. Kettle, A.J.; Turner, R.; Gangell, C.L.; Harwood, D.T.; Khalilova, I.S.; Chapman, A.L.; Winterbourn, C.C.; Sly, P.D.; Arest, C.F. Oxidation contributes to low glutathione in the airways of children with cystic fibrosis. Eur. Respir. J. 2014, 44, 122–129.
  21. Achari, A.E.; Jain, S.K. l-Cysteine supplementation increases insulin sensitivity mediated by upregulation of GSH and adiponectin in high glucose treated 3T3-L1 adipocytes. Arch. Biochem. Biophys. 2017, 630, 54–65.
  22. Sekhar, R.V.; McKay, S.V.; Patel, S.G.; Guthikonda, A.P.; Reddy, V.T.; Balasubramanyam, A.; Jahoor, F. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 2011, 34, 162–167.
  23. Nguyen, D.; Hsu, J.W.; Jahoor, F.; Sekhar, R.V. Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J. Clin. Endocrinol. Metab. 2014, 99, 169–177.
  24. Robaczewska, J.; Kedziora-Kornatowska, K.; Kozakiewicz, M.; Zary-Sikorska, E.; Pawluk, H.; Pawliszak, W.; Kedziora, J. Role of glutathione metabolism and glutathione-related antioxidant defense systems in hypertension. J. Physiol. Pharmacol. 2016, 67, 331–337.
  25. Adeoye, O.; Olawumi, J.; Opeyemi, A.; Christiania, O. Review on the role of glutathione on oxidative stress and infertility. JBRA Assist. Reprod. 2018, 22, 61–66.
  26. Shah, D.; Sah, S.; Nath, S.K. Interaction between glutathione and apoptosis in systemic lupus erythematosus. Autoimmun. Rev. 2013, 12, 741–751.
  27. Nucifora, L.G.; Tanaka, T.; Hayes, L.N.; Kim, M.; Lee, B.J.; Matsuda, T.; Nucifora, F.C., Jr.; Sedlak, T.; Mojtabai, R.; Eaton, W.; et al. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl. Psychiatry 2017, 7, e1215.
  28. Carvalho, A.N.; Lim, J.L.; Nijland, P.G.; Witte, M.E.; Van Horssen, J. Glutathione in multiple sclerosis: More than just an antioxidant? Mult. Scler. 2014, 20, 1425–1431.
  29. Aoyama, K.; Nakaki, T. Impaired glutathione synthesis in neurodegeneration. Int. J. Mol. Sci. 2013, 14, 21021–21044.
  30. Coles, L.D.; Tuite, P.J.; Öz, G.; Mishra, U.R.; Kartha, R.V.; Sullivan, K.M.; Cloyd, J.C.; Terpstra, M. Repeated-dose oral N-Acetylcysteine in Parkinson’s disease: Pharmacokinetics and effect on brain glutathione and oxidative stress. J. Clin. Pharmacol. 2018, 58, 158–167.
  31. Lux, O.; Naidoo, D. Biological variability of superoxide dismutase and glutathione peroxidase in blood. Redox Rep. 1995, 1, 331–335.
  32. Van ‘t Erve, T.J.; Wagner, B.A.; Ryckman, K.K.; Raife, T.J.; Buettner, G.R. The concentration of glutathione in human erythrocytes is a heritable trait. Free Radic. Biol. Med. 2013, 65, 742–749.
  33. Nebert, D.W.; Vasiliou, V. Analysis of the glutathione S-transferase (GST) gene family. Hum. Genom. 2004, 1, 460–464.
  34. Sprenger, R.; Schlagenhaufer, R.; Kerb, R.; Bruhn, C.; Brockmöller, J.; Roots, I.; Brinkmann, U. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 2000, 10, 557–565.
  35. Hollman, A.L.; Tchounwou, P.B.; Huang, H.C. The association between gene-environment interactions and diseases involving the human GST superfamily with SNP variants. Int. J. Environ. Res. Public Health 2016, 13, 379.
  36. Meister, A.; Anderson, M.E. Glutathione. Annu. Rev. Biochem. 1983, 52, 711–760.
  37. Meister, A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 1991, 51, 155–194.
  38. Allen, J.; Bradley, R.D. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J. Altern. Complement. Med. 2011, 17, 827–833.
  39. Witschi, A.; Reddy, S.; Stofer, B.; Lauterburg, B.H. The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol. 1992, 43, 667–669.
  40. Park, E.Y.; Shimura, N.; Konishi, T.; Sauchi, Y.; Wada, S.; Aoi, W.; Nakamura, Y.; Sato, K. Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione. J. Agric. Food Chem. 2014, 62, 6183–6189.
  41. Richie, J.P., Jr.; Nichenametla, S.; Neidig, W.; Calcagnotto, A.; Haley, J.S.; Schell, T.D.; Muscat, J.E. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur. J. Nutr. 2015, 54, 251–263.
  42. McCarty, M.F.; O’Keefe, J.H.; DiNicolantonio, J.J. Dietary glycine is rate-limiting for glutathione synthesis and may have broad potential for health protection. Ochsner J. 2018, 18, 81–87.
  43. U.S. National Library of Medicine. Amino Acids. Available online: https://medlineplus.gov/ency/article/002222.htm (accessed on June 26 2019).
  44. Lu, S.C. Glutathione synthesis. Biochim. Biophys. Acta 2013, 1830, 3143–3153.
  45. Parcell, S. Sulfur in human nutrition and applications in medicine. Altern. Med. Rev. 2002, 7, 22–44.
  46. Jones, D.P.; Park, Y.; Gletsu-Miller, N.; Liang, Y.; Yu, T.; Accardi, C.J.; Ziegler, T.R. Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humans. Nutrition 2011, 27, 199–205.
  47. Skvarc, D.R.; Dean, O.M.; Byrne, L.K.; Gray, L.; Lane, S.; Lewis, M.; Fernanders, B.S.; Berk, M.; Marriott, A. The effect of N-acetylcysteine (NAC) on human cognition—A systematic review. Neurosci. Biobehav. Rev. 2017, 78, 44–56.
  48. Bhutto, A.; Morley, J.E. The clinical significance of gastrointestinal changes with aging. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 651–660.
  49. Corleto, V.D.; Festa, S.; Di Giulio, E.; Annibale, B. Proton pump inhibitor therapy and potential long-term harm. Curr. Opin. Endocrinol. Diabetes Obes. 2014, 21, 3–8.
  50. Dvorshchenko, K.O.; Bernyk, O.O.; Dranytsyna, A.S.; Senin, S.A.; Ostapchenko, L.I. Influence of oxidative stress on the level of genes expression Tgfb1 and Hgf in rat liver upon long-term gastric hypochlorhydria and administration of multiprobiotic Symbiter; Article in Ukrainian. Ukrains’ kyi Biokhimichnyi Zhurnal (1999) 2013, 85, 114–123.
  51. Naito, Y.; Yoshikawa, T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 2002, 33, 323–336.
  52. Cavalcoli, F.; Zilli, A.; Conte, D.; Massironi, S. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review. World J. Gastroenterol. 2017, 23, 563–572.
  53. Jackson, A.A.; Gibson, N.R.; Lu, Y.; Jahoor, F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am. J. Clin. Nutr. 2014, 80, 101–107.
  54. Rahman, I. Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid. Redox. Signal 1999, 1, 425–447.
  55. Duffy, S.L.; Lagopoulos, J.; Cockayne, N.; Lewis, S.J.; Hickie, I.B.; Hermens, D.F.; Naismith, S.L. The effect of 12-wk ω-3 fatty acid supplementation on in vivo thalamus glutathione concentration in patients “at risk” for major depression. Nutrition 2015, 31, 1247–1254.
  56. Taghizadeh, M.; Tamtaji, O.R.; Dadgostar, E.; Daneshvar Kakhaki, R.; Bahmani, F.; Abolhassani, J.; Aarabi, M.H.; Kouchaki, E.; Memarzadeh, M.R.; Asemi, Z. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Neurochem. Int. 2017, 108, 183–189.
  57. Ashoori, M.; Saedisomeolia, A. Riboflavin (vitamin B₂) and oxidative stress: a review. Br. J. Nutr. 2014, 111, 1985–1991.
  58. Majchrzak, D.; Singer, I.; Männer, M.; Rust, P.; Genser, D.; Wagner, K.H.; Elmadfa, I. B-vitamin status and concentrations of homocysteine in Austrian omnivores, vegetarians and vegans. Ann. Nutr. Metab. 2006, 50, 485–491.
  59. Moat, S.J.; Ashfield-Watt, P.A.; Powers, H.J.; Newcombe, R.G.; McDowell, I.F. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem. 2003, 49, 295–302.
  60. Slyshenkov, V.S.; Dymkowska, D.; Wojtczak, L. Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics. FEBS Lett. 2004, 569, 169–172.
  61. Misra, U.K.; Kalita, J.; Singh, S.K.; Rahi, S.K. Oxidative stress markers in Vitamin B12 deficiency. Mol. Neurobiol. 2017, 54, 1278–1284.
  62. Lenton, K.J.; Sané, A.T.; Therriault, H.; Cantin, A.M.; Payette, H.; Wagner, J.R. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am. J. Clin. Nutr. 2003, 77, 189–195.
  63. Johnston, C.S.; Meyer, C.G.; Srilakshmi, J.C. Vitamin C elevates red blood cell glutathione in healthy adults. Am. J. Clin. Nutr. 1993, 58, 103–105.
  64. Chugh, S.N.; Kakkar, R.; Kalra, S.; Sharma, A. An evaluation of oxidative stress in diabetes mellitus during uncontrolled and controlled state and after vitamin E supplementation. J. Assoc. Physic. Ind. 1999, 47, 380–383.
  65. Sharma, A.; Kharb, S.; Chugh, S.N.; Kakkar, R.; Singh, G.P. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 2000, 49, 160–162.
  66. Jain, S.K.; McVie, R.; Smith, T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care. 2000, 23, 1389–1394.
  67. Gupta, S.; Sharma, T.K.; Kaushik, G.G.; Shekhawat, V.P. Vitamin E supplementation may ameliorate oxidative stress in type 1 diabetes mellitus patients. Clin Lab. 2011, 57, 379–386.
  68. Aghadavod, E.; Soleimani, A.; Hamidi, G.; Keneshlou, F.; Heidari, A.; Asemi, Z. Effects of high-dose vitamin E supplementation on markers of cardiometabolic risk and oxidative stress in patients with diabetic nephropathy: A randomized double-blinded controlled trial. Iran J. Kidney Dis. 2018, 12, 156–162.
  69. Kolesnichenko, L.S.; Kulinskiĭ, V.I.; Shprakh, V.V.; Bardymov, V.V.; Verlan, N.V.; Gubina, L.P.; Pensionerova, G.A.; Sergeeva, M.P.; Stanevich, L.M.; Filippova, G.T. The blood glutathione system in cerebral vascular diseases and its treatment with alpha-lipoic acid. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova 2008, 108, 36–40.
  70. Martins, V.D.; Manfredini, V.; Peralba, M.C.; Benfato, M.S. Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients. Clin Nutr. 2009, 28, 192–197.
  71. Ansar, H.; Mazloom, Z.; Kazemi, F.; Hejazi, N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med. J. 2011, 32, 584–588.
  72. Georgakouli, K.; Deli, C.K.; Zalavras, A.; Fatouros, I.G.; Kouretas, D.; Koutedakis, Y.; Jamurtas, A.Z. A-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency. Food Chem. Toxicol. 2013, 61, 69–73.
  73. Khalili, M.; Eghtesadi, S.; Mirshafiey, A.; Eskandari, G.; Sanoobar, M.; Sahraian, M.A.; Motevalian, A.; Norouzi, A.; Moftakhar, S.; Azimi, A. Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial. Nutr. Neurosci. 2014, 17, 16–20.
  74. Zhao, L.; Hu, F.X. α-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 3715–3719.
  75. Becker, K.; Pons-Kühnemann, J.; Fechner, A.; Funk, M.; Gromer, S.; Gross, H.J.; Grünert, A.; Schirmer, R.H. Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor--a pilot study. Redox Rep. 2005, 10, 215–226.
  76. Jariwalla, R.; Lalezari, J.; Cenko, D.; Mansour, S.E.; Kumar, A.; Gangapurkar, B.; Nakamura, D. Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection. J. Altern. Complement. Med. 2008, 14, 139–146.
  77. Song, E.; Su, C.; Fu, J.; Xia, X.; Yang, S.; Xiao, C.; Lu, B.; Chen, H.; Sun, Z.; Wu, S.; et al. Selenium supplementation shows protective effects against patulin-induced brain damage in mice via increases in GSH-related enzyme activity and expression. Life Sci. 2014, 109, 37–43.
  78. Richie, J.P., Jr.; Muscat, J.E.; Ellison, I.; Calcagnotto, A.; Kleinman, W.; El-Bayoumy, K. Association of selenium status and blood glutathione concentrations in blacks and whites. Nutr. Cancer 2011, 63, 367–375.
  79. Galan-Chilet, I.; Tellez-Plaza, M.; Guallar, E.; De Marco, G.; Lopez-Izquierdo, R.; Gonzalez-Manzano, I.; Carmen Tormos, M.; Martin-Nuñez, G.M.; Rojo-Martinez, G.; Saez, G.T.; et al. Plasma selenium levels and oxidative stress biomarkers: a gene-environment interaction population-based study. Free Radic. Biol. Med. 2014, 74, 229–236.
  80. Bouayed, J.; Bohn, T. Exogenous antioxidants—Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell Longev. 2010, 3, 228–237.
  81. Liu, R.H. Dietary bioactive compounds and their health implications. J. Food Sci. 2013, 78 (Suppl. S1), A18–A25.
  82. Fowke, J.H.; Morrow, J.D.; Motley, S.; Bostick, R.M.; Ness, R.M. Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake. Carcinogenesis 2006, 27, 2096–2102.
  83. Visioli, F.; Riso, P.; Grande, S.; Galli, C.; Porrini, M. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J. Nutr. 2003, 42, 201–206.
  84. Thompson, H.J.; Heimendinger, J.; Sedlacek, S.; Haegele, A.; Diker, A.; O’Neill, C.; Meinecke, B.; Wolfe, P.; Zhu, Z.; Jiang, W. 8-Isoprostane F2alpha excretion is reduced in women by increased vegetable and fruit intake. Am. J. Clin. Nutr. 2005, 82, 768–776.
  85. Thompson, H.J.; Heimendinger, J.; Haegele, A.; Sedlacek, S.M.; Gillette, C.; O’Neill, C.; Wolfe, P.; Conry, C. Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. Carcinogenesis 1999, 20, 2261–2266.
  86. Rink, S.M.; Mendola, P.; Mumford, S.L.; Poudrier, J.K.; Browne, J.R.; Eactawski-Wende, J.; Perkins, N.J.; Schisterman, E.F. Self-report of fruit and vegetable intake that meets the 5 a day recommendation is associated with reduced levels of oxidative stress biomarkers and increased levels of antioxidant defense in premenopausal women. J. Acad. Nutr. Diet. 2013, 113, 776–785.
  87. Minich, D.M. A Review of the Science of Colorful, Plant-Based Food and Practical Strategies for Eating the Rainbow. J. Nutr. Metab. 2019, 2019, 19.
  88. Hodges, R.E.; Minich, D.M. Modulation of metabolic detoxification pathways using foods and food-derived components: A scientific Review with clinical application. J. Nutr. Metab. 2015, 2015, 760689.
  89. Vanduchova, A.; Anzenbacher, P.; Anzenbacherova, E. Isothiocyanate from Broccoli, Sulforaphane, and Its Properties. J. Med. Food 2019, 22, 121–126.
  90. Johnson, I.T. Cruciferous vegetables and risk of cancers of the gastrointestinal tract. Mol Nutr Food Res. 2018, 62, e1701000.
  91. Saleh, D.O.; Mansour, D.F.; Hashad, I.M.; Bakeer, R.M. Effects of sulforaphane on D-galactose-induced liver aging in rats: Role of keap-1/nrf-2 pathway. Eur. J. Pharmacol. 2019, 855, 40–49.
  92. Abdull Razis, A.F.; Konsue, N.; Ioannides, C. Isothiocyanates and xenobiotic detoxification. Mol. Nutr. Food Res. 2018, 62, e1700916.
  93. Clapper, M.L.; Szarka, C.E.; Pfeiffer, G.R.; Graham, T.A.; Balshem, A.M.; Litwin, S.; Goosenberg, E.B.; Frucht, H.; Engstrom, P.F. Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clin. Cancer Res. 1997, 3, 25–30.
  94. Liu, P.; Zhang, M.; Xie, X.; Jin, J.; Holman, C.A.J. Green tea consumption and glutathione S-transferases genetic polymorphisms on the risk of adult leukemia. Eur. J. Nutr. 2017, 56, 603–612.
  95. Pourahmadi, Z.; Mahboob, S.; Saedisomeolia, A.; Reykandeh, M.T. The effect of tomato juice consumption on antioxidant status in overweight and obese females. Women Health 2015, 55, 795–804.
  96. Rangel-Huerta, O.D.; Aguilera, C.M.; Martin, M.V.; Soto, M.J.; Rico, M.C.; Vallejo, F.; Tomas-Barberan, F.; Perez-de-la-Cruz, A.J.; Gil, A.; Mesa, M.D. Normal or high polyphenol concentration in orange Juice affects antioxidant activity, blood pressure, and body weight in obese or overweight adults. J. Nutr. 2015, 145, 1808–1816.
  97. Ghavipour, M.; Sotoudeh, G.; Ghorbani, M. Tomato juice consumption improves blood antioxidative biomarkers in overweight and obese females. Clin. Nutr. 2015, 34, 805–809.
  98. Guo, C.; Wei, J.; Yang, J.; Xu, J.; Pang, W.; Jiang, Y. Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects. Nutr. Res. 2008, 28, 72–77.
  99. Singletary, K.W.; Rokusek, J.T. Tissue-specific enhancement of xenobiotic detoxification enzymes in mice by dietary rosemary extract. Plant Foods Hum. Nutr. 1997, 50, 47–53.
  100. Singletary, K.W. Rosemary extract and carnosol stimulate rat liver glutathione-S-transferase and quinone reductase activities. Cancer Lett. 1996, 100, 139–144.
  101. Rašković, A.; Milanović, I.; Pavlović, N.; Ćebović, T.; Vukmirović, S.; Mikov, M. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complement. Altern Med. 2014, 14, 225.
  102. Abrahams, S.; Haylett, W.L.; Johnson, G.; Carr, J.A.; Bardien, S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Neuroscience 2019, 406, 1–21.
  103. Vargas-Mendoza, N.; Madrigal-Santillán, E.; Morales-González, A.; Esquivel-Soto, J.; Esquivel-Chirino, C.; García-Luna, Y.; González-Rubio, M.; Gayosso-de-Lucio, J.A.; Morales-González, J.A. Hepatoprotective effect of silymarin. World J. Hepatol. 2014, 6, 144–149.
  104. Sasaki, K.; Hatta, S.; Wada, K.; Ueda, N.; Yoshimura, T.; Endo, T.; Sakata, M.; Tanaka, T.; Haga, M. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci. 2002, 70, 1657–1667.
  105. Lee, H.Y.; Kim, S.W.; Lee, G.H.; Choi, M.K.; Jung, H.W.; Kim, Y.J.; Kwon, H.J.; Chae, H.J. Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation. BMC Complement. Altern Med. 2016, 16, 316.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback